Apart from bariatric surgery and lifestyle management , very few pharmacological options are available for the treatment of obesity. Lorcaserin is one such drug which has recently got the approval from regulatory bodies for the management of obesity. This is a short overview of this new anti-obesity drug. According to WHO, around 11% Indians are overweight and 24 % out of that are obese. Obesity is a major health issue and always present as a co-morbidity in serious diseases.
Lifestyle management is always a preferred option for obesity treatment. When it fails one has to move to other options like bariatric surgery or medication. Lorcaserin is one such a drug prescribed for the obesity management. MOA and Indications: Lorcaserin is a 5-HT agonist. It decreases food consumption and promotes satiety by selectively activating 5-HT2C receptors on anorexigenic pro-opiomelanocortin neurons…
